SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000898432-24-000401
Filing Date
2024-05-13
Accepted
2024-05-13 16:15:28
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A sc13d-a.htm SC 13D/A 64255
2 PLEDGE AND SECURITY AGREEMENT, DATED AS OF MAY 9, 2024, BY AND BETWEEN TI SIE 2 exh99-5.htm EX-99.5 89741
3 ISSUER LETTER AGREEMENT, DATED AS OF MAY 9, 2024, BY AND BETWEEN AMNEAL PHARMACE exh99-6.htm EX-99.6 33408
  Complete submission text file 0000898432-24-000401.txt   188775
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90473 | Film No.: 24939251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TARSADIA INVESTMENTS 520 NEWPORT CENTER DRIVE, 21ST FLOOR NEWPORT BEACH CA 92660
Business Address
Patel Tushar Bhikhubhai (Filed by) CIK: 0001745375 (see all company filings)

Type: SC 13D/A